COFCO Capital Holdings Co., Ltd. (002423.SZ)
CNY 14.29
(0.0%)
CNY 14.29
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 1.02 Billion CNY | -7.15% |
| 2022 | 1.09 Billion CNY | -46.67% |
| 2021 | 2.06 Billion CNY | 27.34% |
| 2020 | 1.61 Billion CNY | 39.25% |
| 2019 | 1.16 Billion CNY | 336.59% |
| 2018 | -491.3 Million CNY | -65.16% |
| 2017 | -297.46 Million CNY | -5822.86% |
| 2016 | 5.19 Million CNY | 102.44% |
| 2015 | -213.35 Million CNY | -357.42% |
| 2014 | -46.64 Million CNY | -2114.65% |
| 2013 | 2.31 Million CNY | -96.76% |
| 2012 | 71.49 Million CNY | -21.21% |
| 2011 | 90.74 Million CNY | -5.32% |
| 2010 | 95.84 Million CNY | -28.92% |
| 2009 | 134.83 Million CNY | 4.67% |
| 2008 | 128.81 Million CNY | 46.29% |
| 2007 | 88.05 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 546.26 Million CNY | -13.04% |
| 2024 Q1 | 628.18 Million CNY | 339.66% |
| 2024 Q3 | 102.81 Million CNY | -81.18% |
| 2023 FY | 1.02 Billion CNY | -7.15% |
| 2023 Q3 | 125.24 Million CNY | -71.75% |
| 2023 Q4 | -262.11 Million CNY | -309.29% |
| 2023 Q2 | 443.26 Million CNY | 18.03% |
| 2023 Q1 | 375.54 Million CNY | -32.42% |
| 2022 Q4 | 555.7 Million CNY | 585.51% |
| 2022 Q3 | 81.06 Million CNY | -91.09% |
| 2022 Q2 | 909.82 Million CNY | 303.33% |
| 2022 Q1 | -447.44 Million CNY | -180.26% |
| 2022 FY | 1.09 Billion CNY | -46.67% |
| 2021 FY | 2.06 Billion CNY | 27.34% |
| 2021 Q4 | 557.51 Million CNY | 13.05% |
| 2021 Q2 | 489.39 Million CNY | 142.09% |
| 2021 Q1 | 202.15 Million CNY | 68.13% |
| 2021 Q3 | 493.15 Million CNY | 0.77% |
| 2020 FY | 1.61 Billion CNY | 39.25% |
| 2020 Q3 | 338.26 Million CNY | -15.89% |
| 2020 Q2 | 402.16 Million CNY | 108.51% |
| 2020 Q1 | 192.87 Million CNY | 603.86% |
| 2020 Q4 | 120.23 Million CNY | -64.45% |
| 2019 Q3 | 141.25 Million CNY | -39.29% |
| 2019 FY | 1.16 Billion CNY | 336.59% |
| 2019 Q1 | 316.51 Million CNY | 763.95% |
| 2019 Q2 | 232.68 Million CNY | -26.49% |
| 2019 Q4 | -38.27 Million CNY | -127.1% |
| 2018 FY | -491.3 Million CNY | -65.16% |
| 2018 Q4 | -47.67 Million CNY | -145.28% |
| 2018 Q3 | -19.43 Million CNY | -59.77% |
| 2018 Q2 | -12.16 Million CNY | 63.62% |
| 2018 Q1 | -33.43 Million CNY | 69.85% |
| 2017 Q4 | -110.89 Million CNY | -133.58% |
| 2017 FY | -297.46 Million CNY | -5822.86% |
| 2017 Q1 | -38.46 Million CNY | -140.61% |
| 2017 Q2 | -61.08 Million CNY | -58.81% |
| 2017 Q3 | -47.47 Million CNY | 22.29% |
| 2016 Q2 | -27.55 Million CNY | -29.93% |
| 2016 FY | 5.19 Million CNY | 102.44% |
| 2016 Q4 | 94.72 Million CNY | 332.38% |
| 2016 Q3 | -40.76 Million CNY | -47.92% |
| 2016 Q1 | -21.2 Million CNY | 85.8% |
| 2015 FY | -213.35 Million CNY | -357.42% |
| 2015 Q1 | -12.13 Million CNY | 54.91% |
| 2015 Q2 | -11.93 Million CNY | 1.66% |
| 2015 Q3 | -39.94 Million CNY | -234.62% |
| 2015 Q4 | -149.32 Million CNY | -273.81% |
| 2014 Q2 | 1.02 Million CNY | 109.58% |
| 2014 FY | -46.64 Million CNY | -2114.65% |
| 2014 Q3 | -10.06 Million CNY | -1084.93% |
| 2014 Q1 | -10.66 Million CNY | -124.32% |
| 2014 Q4 | -26.92 Million CNY | -167.42% |
| 2013 Q2 | -9.84 Million CNY | 54.76% |
| 2013 Q1 | -21.76 Million CNY | -136.13% |
| 2013 FY | 2.31 Million CNY | -96.76% |
| 2013 Q4 | 43.86 Million CNY | 541.15% |
| 2013 Q3 | -9.94 Million CNY | -0.99% |
| 2012 Q2 | -2.73 Million CNY | -135.35% |
| 2012 FY | 71.49 Million CNY | -21.21% |
| 2012 Q4 | 60.23 Million CNY | 859.98% |
| 2012 Q3 | 6.27 Million CNY | 329.75% |
| 2012 Q1 | 7.72 Million CNY | -76.43% |
| 2011 Q2 | 40.66 Million CNY | 559.98% |
| 2011 Q1 | 6.16 Million CNY | -82.96% |
| 2011 FY | 90.74 Million CNY | -5.32% |
| 2011 Q3 | 11.15 Million CNY | -72.57% |
| 2011 Q4 | 32.76 Million CNY | 193.75% |
| 2010 FY | 95.84 Million CNY | -28.92% |
| 2010 Q1 | 28.71 Million CNY | 0.74% |
| 2010 Q2 | 18.71 Million CNY | -34.83% |
| 2010 Q3 | 12.24 Million CNY | -34.55% |
| 2010 Q4 | 36.16 Million CNY | 195.26% |
| 2009 Q3 | 28.68 Million CNY | -32.26% |
| 2009 Q1 | 35.29 Million CNY | 0.0% |
| 2009 Q2 | 42.34 Million CNY | 20.0% |
| 2009 FY | 134.83 Million CNY | 4.67% |
| 2009 Q4 | 28.5 Million CNY | -0.63% |
| 2008 FY | 128.81 Million CNY | 46.29% |
| 2007 FY | 88.05 Million CNY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Hubei Biocause Pharmaceutical Co., Ltd. | -651.75 Million CNY | 256.588% |